Interleukin-10 promoter polymorphisms in giant cell arteritis

Arthritis and Rheumatism

Volumn 54, Issue 12, 2006, Pages 4011-4017

  Boiardi, Luigi ^a   Casali, Bruno ^a   Farnetti, Enrico ^a   Pipitone, Nicolò ^a   Nicoli, Davide ^a   Macchioni, PierLuigi ^a   Cimino, Luca ^a   Bajocchi, GianLuigi ^a   Catanoso, Maria Grazia ^a   Pattacini, Laura ^a   Salvarani, Carlo ^a,b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b Servizio di Reumatologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADULT; AGED; AORTA ARCH SYNDROME; ARTICLE; CEREBROVASCULAR ACCIDENT; CLAUDICATION; CLINICAL FEATURE; DNA POLYMORPHISM; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; GIANT CELL ARTERITIS; HAPLOTYPE; HETEROZYGOTE; HUMAN; ISCHEMIA; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATIC POLYMYALGIA; VISUAL IMPAIRMENT;

AGED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; INTERLEUKIN-10; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TEMPORAL ARTERITIS;

EID: 33845633733     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22218     Document Type: Article

References (47)

1. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 2003;349:160-9.
2. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
3. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
4. Eskdale J , Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998;95:9465-70.
5. Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1999;1:151-5.
6. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999;42:1101-8.
7. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999;30:526-30.
8. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 2000;1:185-90.
9. Kurreeman FA, Schonkeren JJ, Heijmans BT, Toes RE, Huizinga TW. Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level. Hum Mol Genet 2004;13:1755-6.
10. Keijsers V, Verweij CL, Westendorp RG, Breedveld FC, Huizinga TW. IL-10 polymorphisms in relation to production and rheumatoid arthritis (RA) [abstract]. Arthritis Rheum 1997;40 Suppl 9:S179.
11. Gonzalez-Gay MA, Boiardi L, Garcia-Porrua C, Macchioni P, Amor-Dorado JC, Salvarani C. Geographical and genetic factors do not account for significant differences in the clinical spectrum of giant cell arteritis in southern Europe. J Rheumatol 2004;31:520-3.
12. Salvarani C, Macchioni PL, Tartoni PL, Rossi F. Baricchi R, Castri C, et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy. Clin Exp Rheumatol 1987;5:205-15.
13. Santos AR, Suffys PN, Vanderborght PR, Moraes MO, Vieira LM, Cabello PH, et al. Role of tumor necrosis factor-α and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis 2002;186:1687-91.
14. Tseng LH, Chen PJ, Lin MT, Singleton K, Martin EG, Yen AH, et al. Simultaneous genotyping of single nucleotide polymorphisms in the IL-6, IL-10, TNFα and TNFβ genes. Tissue Antigens 2002;59:280-6.
15. Halperin E, Eskin E. Haplotype reconstruction from genotype data using Imperfect Phylogeny. Bioinformatics 2004;20:1842-9.
16. Skapenko A, Niedobitek GU, Kalden JR, Lipsky PE, Schulze-Koops H. Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10. J Immunol 2004;172:6427-34.
17. Trinchieri G. Regulatory role of T cells producing both Interferon γ and interleukin 10 in persistent infection. J Exp Med 2001;194: F53-7.
18. Jiang H, Chess L. Regulation of immune responses by T cells. N Engl J Med 2006;354:1166-76.
19. Van Roon JA, Lafeber FP, Bijlsma JW. Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis [review]. Arthritis Rheum 2001;44:3-12.
20. McInnes IB, Illei GG, Danning CL, Yarboro CH, Crane M, Kuroiwa T, et al. IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis. J Immunol 2001;167:4075-82.
21. Weyand CM, Goronzy JJ. The pathogenic role of T lymphocytes in vasculitis. Sarcoidosis Vase Diffuse Lung Dis 1996;13:217-20.
22. Dorman SE, Holland SM. Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection. J Clin Invest 1998;101:2364-9.
23. Ludviksson BR, Sneller MC, Chua KS, Talar-Williams C, Langford CA, Ehrhardt RO, et al. Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 1998;160:3602-9.
24. Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26.
25. Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Amoli MM, Llorca J, et al. Interferon-γ gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol 2004;22 Suppl 36:818-20.
26. Gonzalez-Gay MA, Di Giovine FS, Silvestri T, Amoli MM, Garcia-Porrua C, Thomson W, et al. Lack of association between IL-1 cluster and TNF-α gene polymorphisms and giant cell arteritis. Clin Exp Rheumatol 2002;20:431.
27. Ito S, Ansari P, Sakatsume M, Dickensheets H, Vazquez N, Donnelly RP, et al. Interleukin-10 inhibits expression of both Interferon α- and Interferon γ-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 1999;93:1456-63.
28. Kingo K, Koks S, Silm H, Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun 2003;4:455-7.
29. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, et al. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun 2003;4:234-8.
30. Arosio B. Trabattoni D. Galimberti L, Bucciarelli P, Fasano F, Calabresi C, et al. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol Aging 2004;25:1009-15.
31. Ma SL, Tang NL, Lam LC, Chiu HF. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease. Neurobiol Aging 2005;26:1005-10.
32. George S, Ruan XZ, Navarrete C, Turner D, Reynard M, Sweny P, et al. Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens 2004;63:470-5.
33. Bown MJ, Burton PR, Horsburgh T, Nicholson ML, Bell PR, Sayers RD. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: a case-control study. J Vasc Surg 2003;37:999-1005.
34. Lio D, Candore G, Crivello A, Scola L, Colonna-Romano G, Cavallone L, et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet 2004;41:790-4.
35. Shih CM, Lee YL, Chiou HL, Hsu WF, Chen WE, Chou MC, et al. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer 2005;50:291-7.
36. Lowe PR, Galley HF, Abdel-Fattah A, Webster NR. Influence of interleukin-10 polymorphisms on interleukin-10 expression and survival in critically ill patients. Crit Care Med 2003;31:34-8.
37. Stanilova SA, Miteva LD, Karakolev ZT, Stefanov CS. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med 2006;32:260-6.
38. Pawlik A, Kurzawski M, Szklarz BG, Herczynska M, Drozdzik M. Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clin Rheumatol 2005;24:480-4.
39. Font J, Garcia-Carrasco M, Ramos-Casals M, Aldea AI, Cervera R, Ingelmo M, et al. The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjögren's syndrome. Rheumatology 2002;41:1025-30.
40. Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Arthritis Rheum 2001;44:176-9.
41. Origuchi T, Kawasaki E, Ide A, Kamachi M, Tanaka F, Ida H, et al. Correlation between interleukin 10 gene promoter region polymorphisms and clinical manifestations in Japanese patients with Sjögren's syndrome. Ann Rheum Dis 2003;62:1117-8.
42. Crilly A, Hamilton J, Clark CJ, Jardine A, Madhok R. Analysis of the 5′ flanking region of the interleukin 10 gene in patients with systemic sclerosis. Rheumatology (Oxford) 2003;42:1295-8.
43. Khoa PD, Sugiyama T, Yokochi T. Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 2005;24:11-3.
44. Rood MJ, Keijsers V, van der Linden MW, Tong TQ, Borggreve SE, Verweij CL, et al. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann Rheum Dis 1999;58:85-9.
45. Murakozy G, Gaede KI, Ruprecht B, Gutzeit O, Schurmann M, Schnabel A, et al. Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis. J Mol Med 2001;79:665-70.
46. Bartfai Z, Gaede KI, Russell KA, Murakozy G, Muller-Quernheim J, Specks U. Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin Immunol 2003;109:330-7.
47. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors: a twin study. Genes Immun 2002;3:407-13.